FDA warning letter · Drugs

Northern VA Compounders PLLC, dba Akina Pharmacy

Issued · Posted by FDA

Selected passages from the FDA letter

Quoted FDA text from the published dataset. These selected excerpts are not the complete letter.

Passage 1

Your firm failed to confirm that the quality of water was suitable for its intended use in the production of non-sterile drug products.

Passage 2

Your firm failed to perform adequate smoke studies under dynamic conditions to demonstrate unidirectional airflow within the ISO **(b)(4)** area. Therefore, your products intended to be sterile are produced in an environment that may not provide adequate protection against the risk of contamination.